Managing Our Microbial Mark: What We Can Learn About Pay for Performance From Ebola's Arrival at Our Shores

American Journal of Law & Medicine
Ann Marie Marciarille

Abstract

The narrative of Ebola's arrival in the United States has been overwhelmed by our fear of a West African-style epidemic. The real story of Ebola's arrival is about our healthcare system's failure to identify, treat, and contain healthcare associated infections. Having long been willfully ignorant of the path of fatal infectious diseases through our healthcare facilities, this paper considers why our reimbursement and quality reporting systems made it easy for this to be so. West Africa's challenges in controlling Ebola resonate with our own struggles to standardize, centralize, and enforce infection control procedures in American healthcare facilities.

Methods Mentioned

BETA
hysterectomies

Software Mentioned

EMTALA

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Medicine, Conflict, and Survival
Shirley Hodgson
BMJ : British Medical Journal
Jane Feinmann
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Charlotte Haug
Archives of Ophthalmology
H Dunbar Hoskins
© 2022 Meta ULC. All rights reserved